Article info
Original research
Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas
- Correspondence to Ms Cassandra B Dowson, Genetic Services of Western Australia, King Edward Memorial Hospital for Women Perth, Subiaco, WA 6008, Australia; Cassandra.dowson{at}health.wa.gov.au
Citation
Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas
Publication history
- Received April 14, 2019
- Revision received September 16, 2019
- Accepted October 7, 2019
- First published November 7, 2019.
Online issue publication
January 03, 2020
Article Versions
- Previous version (7 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.